International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(9), P. 7808 - 7808
Published: April 25, 2023
Biomaterial-based
therapies
have
been
receiving
attention
for
treating
microbial
infections
mainly
to
overcome
the
increasing
number
of
drug-resistant
bacterial
strains
and
off-target
impacts
therapeutic
agents
by
conventional
strategies.
A
fibrous,
non-soluble
protein,
collagen,
is
one
most
studied
biopolymers
development
antimicrobial
biomaterials
owing
its
superior
physicochemical,
biomechanical,
biological
properties.
In
this
study,
we
reviewed
different
approaches
used
develop
collagen-based
devices,
such
as
non-pharmacological,
antibiotic,
metal
oxide,
peptide,
herbal
extract-based,
combination
approaches,
with
a
particular
focus
on
preclinical
studies
that
published
in
last
decade.
Pathogens,
Journal Year:
2023,
Volume and Issue:
12(9), P. 1074 - 1074
Published: Aug. 23, 2023
Antibiotic
resistance
is
a
significant
global
health
concern
that
affects
both
human
and
animal
populations.
The
One
Health
approach
acknowledges
the
interconnectedness
of
health,
environment.
It
emphasizes
importance
collaboration
coordination
across
these
sectors
to
tackle
complex
challenges
such
as
antibiotic
resistance.
In
context
Health,
refers
ability
bacteria
withstand
efficacy
antibiotics,
rendering
them
less
effective
or
completely
ineffective
in
treating
infections.
emergence
spread
antibiotic-resistant
pose
threat
well
effectiveness
medical
treatments
veterinary
interventions.
particular,
recognizes
use
medicine,
agriculture,
environment
are
interconnected
factors
contributing
development
For
example,
misuse
overuse
antibiotics
healthcare,
including
inappropriate
prescribing
patient
non-compliance,
can
contribute
selection
resistant
bacteria.
Similarly,
livestock
production
for
growth
promotion
disease
prevention
animals
subsequent
transmission
humans
through
food
chain.
Addressing
requires
collaborative
involves
multiple
participants,
healthcare
professionals,
veterinarians,
researchers,
policymakers.
Molecules,
Journal Year:
2023,
Volume and Issue:
28(15), P. 5915 - 5915
Published: Aug. 6, 2023
Actinomycetes
inhabit
both
terrestrial
and
marine
ecosystems
are
highly
proficient
in
producing
a
wide
range
of
natural
products
with
diverse
biological
functions,
including
antitumor,
immunosuppressive,
antimicrobial,
antiviral
activities.
In
this
review,
we
delve
into
the
life
cycle,
ecology,
taxonomy,
classification
actinomycetes,
as
well
their
varied
bioactive
metabolites
recently
discovered
between
2015
2023.
Additionally,
explore
promising
strategies
to
unveil
investigate
new
metabolites,
encompassing
genome
mining,
activation
silent
genes
through
signal
molecules,
co-cultivation
approaches.
By
presenting
comprehensive
up-to-date
hope
offer
potential
solution
uncover
novel
compounds
essential
World Journal of Emergency Surgery,
Journal Year:
2023,
Volume and Issue:
18(1)
Published: Oct. 16, 2023
Abstract
Antibiotics
are
recognized
widely
for
their
benefits
when
used
appropriately.
However,
they
often
inappropriately
despite
the
importance
of
responsible
use
within
good
clinical
practice.
Effective
antibiotic
treatment
is
an
essential
component
universal
healthcare,
and
it
a
global
responsibility
to
ensure
appropriate
use.
Currently,
pharmaceutical
companies
have
little
incentive
develop
new
antibiotics
due
scientific,
regulatory,
financial
barriers,
further
emphasizing
To
address
this
issue,
Global
Alliance
Infections
in
Surgery
established
international
multidisciplinary
task
force
295
experts
from
115
countries
with
different
backgrounds.
The
developed
position
statement
called
WARNING
(Worldwide
Antimicrobial
Resistance
National/International
Network
Group)
aimed
at
raising
awareness
antimicrobial
resistance
improving
prescribing
practices
worldwide.
outlined
10
axioms,
or
“golden
rules,”
that
all
healthcare
workers
should
consistently
adhere
Infection and Drug Resistance,
Journal Year:
2023,
Volume and Issue:
Volume 16, P. 7641 - 7662
Published: Dec. 1, 2023
Antimicrobial
resistance
(AMR)
represents
a
major
threat
to
global
health.
Infection
caused
by
Methicillin-resistant
Staphylococcus
aureus
(MRSA)
is
one
of
the
well-recognized
public
health
problem
globally.
In
some
regions,
as
many
90%
S.
infections
are
reported
be
MRSA,
which
cannot
treated
with
standard
antibiotics.
WHO
reports
indicated
that
MRSA
circulating
in
every
province
worldwide,
significantly
increasing
risk
death
64%
compared
drug-sensitive
forms
infection
attributed
its
antibiotic
resistance.
The
emergence
and
spread
antibiotic-resistant
strains
have
contributed
increased
prevalence
both
healthcare
community
settings.
methicillin
due
expression
penicillin-binding
protein
2a
(PBP2a),
renders
it
impervious
action
β-lactam
antibiotics
including
methicillin.
other
through
production
beta-lactamases.
Although
treatment
options
for
limited,
there
promising
alternatives
combat
infections.
Innovative
therapeutic
strategies
wide
range
activity
modes
yet
explored.
review
highlights
challenges
posed
elucidates
mechanisms
underlying
development,
explores
mitigation
strategies.
Furthermore,
focuses
on
alternative
therapies
such
bacteriophages,
immunotherapy,
nanobiotics,
antimicrobial
peptides,
emphasizing
their
synergistic
effects
efficacy
against
MRSA.
By
examining
these
approaches,
this
provides
insights
into
potential
tackling
combatting
escalating
AMR.
Ultimately,
multifaceted
approach
encompassing
conventional
novel
interventions
imperative
mitigate
impact
ensure
sustainable
future
healthcare.
Antibiotics,
Journal Year:
2024,
Volume and Issue:
13(1), P. 46 - 46
Published: Jan. 4, 2024
Sepsis
globally
accounts
for
an
alarming
annual
toll
of
48.9
million
cases,
resulting
in
11
deaths,
and
inflicts
economic
burden
approximately
USD
38
billion
on
the
United
States
healthcare
system.
The
rise
multidrug-resistant
organisms
(MDROs)
has
elevated
urgency
surrounding
management
(MDR)
sepsis,
evolving
into
a
critical
global
health
concern.
This
review
aims
to
provide
comprehensive
overview
current
epidemiology
sepsis
its
associated
challenges,
particularly
critically
ill
hospitalized
patients.
Highlighted
findings
demonstrated
complex
nature
pathophysiology
immune
responses,
which
significantly
hinder
treatment.
Studies
also
revealed
that
aging,
antibiotic
overuse
or
abuse,
inadequate
empiric
therapy,
underlying
comorbidities
contribute
recurrent
thereby
leading
septic
shock,
multi-organ
failure,
ultimately
paralysis,
all
high
mortality
rates
among
Moreover,
studies
confirmed
correlation
between
readmission
increased
risk
cognitive
organ
dysfunction
patients,
amplifying
hospital-associated
costs.
To
mitigate
impact
burden,
researchers
have
directed
their
efforts
towards
innovative
diagnostic
methods
like
point-of-care
testing
(POCT)
devices
rapid,
accurate,
bedside
detection
sepsis;
however,
these
are
currently
limited
detecting
only
few
resistance
biomarkers,
thus
warranting
further
exploration.
Numerous
interventions
been
introduced
treat
MDR
including
combination
therapy
with
antibiotics
from
two
different
classes
precision
involves
personalized
treatment
strategies
tailored
individual
needs.
Finally,
addressing
MDR-associated
challenges
at
regional
levels
based
local
pathogen
patterns
emerges
as
strategy
effective
minimizing
adverse
effects.
Pharmaceutics,
Journal Year:
2024,
Volume and Issue:
16(1), P. 151 - 151
Published: Jan. 22, 2024
The
unique
properties
of
ionic
liquids
(ILs),
such
as
structural
tunability,
good
solubility,
chemical/thermal
stability,
favorable
biocompatibility,
and
simplicity
preparation,
have
led
to
a
wide
range
applications
in
the
pharmaceutical
biomedical
fields.
ILs
can
not
only
speed
up
chemical
reaction
process,
improve
yield,
reduce
environmental
pollution
but
also
many
problems
field
medicine,
poor
drug
product
crystal
instability,
biological
activity,
low
delivery
efficiency.
This
paper
presents
systematic
concise
analysis
recent
advancements
further
from
aspects
synthesis,
analysis,
solubilization,
engineering.
Additionally,
it
explores
field,
covering
carriers,
stabilization
proteins,
antimicrobials,
bioactive
liquids.
Microorganisms,
Journal Year:
2024,
Volume and Issue:
12(9), P. 1920 - 1920
Published: Sept. 21, 2024
Antimicrobial
resistance
(AMR),
frequently
considered
a
major
global
public
health
threat,
requires
comprehensive
understanding
of
its
emergence,
mechanisms,
advances,
and
implications.
AMR’s
epidemiological
landscape
is
characterized
by
widespread
prevalence
constantly
evolving
patterns,
with
multidrug-resistant
organisms
(MDROs)
creating
new
challenges
every
day.
The
most
common
mechanisms
underlying
AMR
(i.e.,
genetic
mutations,
horizontal
gene
transfer,
selective
pressure)
contribute
to
the
emergence
dissemination
resistant
strains.
Therefore,
mitigation
strategies
(e.g.,
antibiotic
stewardship
programs—ASPs—and
infection
prevention
control
strategies—IPCs)
emphasize
importance
responsible
antimicrobial
use
surveillance.
A
One
Health
approach
interconnectedness
human,
animal,
environmental
health)
highlights
necessity
for
interdisciplinary
collaboration
holistic
in
combating
AMR.
Advancements
novel
therapeutics
alternative
agents
vaccines)
offer
promising
avenues
addressing
challenges.
Policy
interventions
at
international
national
levels
also
promote
ASPs
aiming
regulate
use.
Despite
all
observed
progress,
remains
pressing
concern,
demanding
sustained
efforts
address
emerging
threats
sustainability.
Future
research
must
prioritize
innovative
approaches
complex
socioecological
dynamics
This
manuscript
resource
researchers,
policymakers,
healthcare
professionals
seeking
navigate
develop
effective
mitigation.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: Aug. 16, 2024
Antibacterial
drug
resistance
poses
a
significant
challenge
to
modern
healthcare
systems,
threatening
our
ability
effectively
treat
bacterial
infections.
This
review
aims
provide
comprehensive
overview
of
the
types
and
mechanisms
antibacterial
resistance.
To
achieve
this
aim,
thorough
literature
search
was
conducted
identify
key
studies
reviews
on
mechanisms,
strategies
next-generation
antimicrobials
contain
antimicrobial
In
review,
major
with
examples
including
target
site
modifications,
decreased
influx,
increased
efflux
pumps,
enzymatic
inactivation
antibacterials
has
been
discussed.
Moreover,
biofilm
formation,
horizontal
gene
transfer
methods
also
included.
Furthermore,
measures
(interventions)
taken
control
have
discussed
in
detail.
Overall,
provides
valuable
insights
into
diverse
employed
by
bacteria
resist
effects
drugs,
aim
informing
future
research
guiding
stewardship
efforts.
Frontiers in Public Health,
Journal Year:
2022,
Volume and Issue:
10
Published: Oct. 18, 2022
The
coronavirus
disease
2019
(COVID-19)
pandemic
has
influenced
antibiotic
consumption
over
a
long
period,
with
variability
in
trends
among
studies.
We
conducted
this
systematic
review
to
explore
and
compare
the
effect
of
on
overall
individual
2020
that
2019.